Standout Papers
Immediate Impact
5 from Science/Nature 56 standout
Citing Papers
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
BRAF — a tumour-agnostic drug target with lineage-specific dependencies
2024 Standout
Works of Vijay Peddareddigari being referenced
Simultaneous Targeting of CD19 and CD22: Phase I Study of AUTO3, a Bicistronic Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL): Amelia Study
2018
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
2012 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Vijay Peddareddigari | 592 | 705 | 112 | 179 | 18 | 1.1k | |
| Lidia Moserle | 487 | 640 | 169 | 111 | 25 | 1.1k | |
| Laith Dabbagh | 539 | 546 | 209 | 188 | 23 | 1.3k | |
| Katrin E. Rhodes | 555 | 568 | 150 | 310 | 21 | 1.3k | |
| Giorgia Migliardi | 710 | 507 | 95 | 346 | 28 | 1.3k | |
| Gilbert O’Young | 577 | 711 | 179 | 145 | 22 | 1.4k | |
| Cristina Basilico | 347 | 664 | 127 | 144 | 31 | 1.3k | |
| Ricardo Costa | 397 | 489 | 109 | 209 | 17 | 1.0k | |
| Sujatha Jagadeeswaran | 357 | 457 | 99 | 166 | 16 | 959 | |
| Ivan Ischenko | 505 | 619 | 87 | 140 | 22 | 1.2k | |
| J. Rafael Sierra | 357 | 571 | 192 | 245 | 18 | 1.1k |
All Works
Loading papers...